Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G, De Luca S, Oderda M, Munoz F, Krengli M, Allis S, Baima CG, Barale M, Bartoncini S, Beldì D, Bellei L, Bellissimo AR, Bernardi D, Biamino G, Billia M, Borsa R, Cante D, Castelli E, Cattaneo G, Centrella D, Collura D, Coppola P, Dalmasso E, Di Stasio A, Fasolis G, Fiorio M, Garibaldi E, Girelli G, Griffa D, Guercio S, Migliari R, Molinaro L, Montefiore F, Montefusco G, Moroni M, Muto G, Ponti di Sant'Angelo F, Ruggiero L, Ruo Redda MG, Serao A, Squeo MS, Stancati S, Surleti D, Varvello F, Volpe A, Zaramella S, Zarrelli G, Zitella A, Bollito E, Gontero P, Porpiglia F, Galassi C, Bertetto O; START Collaborative Group. Ciccone G, et al. Among authors: ruo redda mg. JAMA Netw Open. 2023 Oct 2;6(10):e2338039. doi: 10.1001/jamanetworkopen.2023.38039. JAMA Netw Open. 2023. PMID: 37847502 Free PMC article.
Radiotherapy-induced taste impairment.
Ruo Redda MG, Allis S. Ruo Redda MG, et al. Cancer Treat Rev. 2006 Nov;32(7):541-7. doi: 10.1016/j.ctrv.2006.06.003. Epub 2006 Aug 2. Cancer Treat Rev. 2006. PMID: 16887272 Review.
Radiotherapy alone or with concomitant daily low-dose carboplatin in locally advanced, unresectable head and neck cancer: definitive results of a phase III study with a follow-up period of up to ten years.
Ruo Redda MG, Ragona R, Ricardi U, Beltramo G, Rampino M, Gabriele P, Allis S, La Porta MR, Moro G, Melano A, Gabriele AM, Tessa M, Fossati P, Orecchia R. Ruo Redda MG, et al. Tumori. 2010 Mar-Apr;96(2):246-53. doi: 10.1177/030089161009600210. Tumori. 2010. PMID: 20572581 Clinical Trial.
Volumetric and positional changes of planning target volumes and organs at risk using computed tomography imaging during intensity-modulated radiation therapy for head-neck cancer: an "old" adaptive radiation therapy approach.
Reali A, Anglesio SM, Mortellaro G, Allis S, Bartoncini S, Ruo Redda MG, Arcadipane F. Reali A, et al. Among authors: ruo redda mg. Radiol Med. 2014 Sep;119(9):714-20. doi: 10.1007/s11547-014-0386-z. Epub 2014 Feb 8. Radiol Med. 2014. PMID: 24510758
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences.
Buttigliero C, Allis S, Tucci M, Zichi C, Leone G, Di Stefano RF, Ruo Redda MG, Ricardi U, Scagliotti GV, Di Maio M, Filippi AR. Buttigliero C, et al. Among authors: ruo redda mg. Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20. Cancer Treat Rev. 2018. PMID: 30096699 Review.
Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.
Franco P, Arcadipane F, Trino E, Gallio E, Martini S, Iorio GC, Piva C, Moretto F, Ruo Redda MG, Verna R, Tseroni V, Bona C, Pozzi G, Fiandra C, Ragona R, Bertetto O, Ricardi U. Franco P, et al. Among authors: ruo redda mg. Clin Transl Radiat Oncol. 2018 Jun 11;11:33-39. doi: 10.1016/j.ctro.2018.06.002. eCollection 2018 Jun. Clin Transl Radiat Oncol. 2018. PMID: 29928706 Free PMC article.
37 results